SULIMAN SHEHNAAZ
SEC Form 4 insider trading activity
SULIMAN SHEHNAAZ has filed 5 SEC Form 4 filings (12 transaction rows) across 2 companies, including TXG, RARE, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2026.
On the most recent filing, SULIMAN SHEHNAAZ is listed as Director at 10x Genomics, Inc. Inside the rolling window, SULIMAN SHEHNAAZ reported no open-market purchases and 4 open-market sales totaling $936K in TXG and RARE. The largest disclosed transaction in the window is a sale of 5,723 TXG shares on Sep 22, 2026, worth $465K.
Companies traded
Other insiders at TXG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$936K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SULIMAN SHEHNAAZ made?
SULIMAN SHEHNAAZ has filed 5 SEC Form 4 filings (12 transaction rows) across 2 companies, including TXG, RARE since 2026.
Which companies does SULIMAN SHEHNAAZ trade?
SULIMAN SHEHNAAZ has filed SEC Form 4 disclosures for 2 companies, including TXG, RARE.
When was SULIMAN SHEHNAAZ's most recent SEC Form 4 filing?
SULIMAN SHEHNAAZ's most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2026.
What is SULIMAN SHEHNAAZ's total buy and sell value in the current window?
Inside the rolling retention window, SULIMAN SHEHNAAZ bought $0 and sold $936K based on SEC Form 4 filings.
What was SULIMAN SHEHNAAZ's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,723 TXG shares on 2026-09-22, worth $465K, per SEC Form 4 filings.